Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 282Unknown 48Active not recruiting 48Terminated 32Recruiting 20Withdrawn 11Not yet recruiting 2Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 15INDUSTRY 8OTHER_GOV 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 5Other hematologic neoplasm 5CNS 5Lymphoid 4Gastrointestinal 4Breast 4Thoracic 3Myeloid 3Tumor-Agnostic 2Plasma cell 2Genitourinary 2Dermatologic 2Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Ovarian Neoplasms 1Neoplasm Metastasis 1

Interventions

X-Rays 1Specimen Handling 1Phantoms, Imaging 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × NIH × Gynecologic × Clear all
NCT04840589 2026-05-13

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

National Cancer Institute (NCI)

Phase 1 Suspended
66 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡